Latest / Business Growth Spotlight
Ep. 154 Why Biotech Startups Fail at Execution and How 3Helix Does It Differently
Show Notes:
In this episode of Business Growth Spotlight, Heidi Schalk sits down with Toby from 3Helix to explore how biotech startups move from breakthrough science to real world commercialization. Toby shares his journey as an MD MBA leader navigating venture capital, startup strategy, and regulatory complexity while helping 3Helix pioneer extracellular matrix based therapies that target disease by changing the cellular environment.
This conversation dives deep into startup strategy, physician leadership, go to market execution, and why credibility matters more than trying to do everything…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.